Tennessee SB0205 requires TennCare health benefit plans to cover biomarker testing for preeclampsia.

Tennessee SB0205 amends Tennessee Code to mandate that TennCare health benefit plans provide coverage and reimbursement for biomarker testing for preeclampsia. This coverage must be available for pregnant women starting July 1, 2025, when ordered by their attending physician. Biomarker testing involves analyzing a patient's tissue, blood, or other biospecimen for biomarkers using FDA-approved methods. The testing must be conducted by the physician or healthcare provider managing the woman's prenatal care, following nationally recognized clinical guidelines.

Tennessee SB0205 requires TennCare health benefit plans to cover biomarker testing for preeclampsia.

Tennessee SB0205 amends Tennessee Code to mandate that TennCare health benefit plans provide coverage and reimbursement for biomarker testing for preeclampsia. This coverage must be available for pregnant women starting July 1, 2025, when ordered by their attending physician. Biomarker testing involves analyzing a patient's tissue, blood, or other biospecimen for biomarkers using FDA-approved methods. The testing must be conducted by the physician or healthcare provider managing the woman's prenatal care, following nationally recognized clinical guidelines.